← All companies

RNTX

Rein Therapeutics Inc.

RNTX Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.75

+0.01 +1.15%

Key statistics

from XBRL data in SEC filings

Market cap

$63.8M

Revenue (TTM)

$0.00

Net income (TTM)

-$50.2M

EPS (TTM)

$-1.90

P/E ratio

—

Dividend yield

—

Free cash flow

-$19.5M

Cash

$4.45M

Total assets

$26.3M

Gross margin

—

52-week range

$0.73 – $2.18

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jul 21, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Entered a material agreement; Other events May 4, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 2, 2026 8-K Director or officer change Feb 19, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jan 16, 2026 8-K Terminated a material agreement Dec 11, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Other events Nov 3, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Oct 24, 2025 8-K Other events Oct 9, 2025 8-K Other events Sep 22, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Sep 9, 2025 8-K Other events Aug 19, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jul 30, 2025 8-K Shareholder vote results Jul 23, 2025 8-K Amended charter or bylaws; Other events Jul 11, 2025 8-K Other events Jun 24, 2025 8-K Other events Jun 12, 2025 8-K Results of operations (earnings release) May 15, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 8-K Entered a material agreement; Unregistered sale of equity Apr 22, 2025 8-K Changed accountants Apr 17, 2025 10-K Fiscal year ended 2024-12-31 Apr 7, 2025 8-K Amended charter or bylaws; Other events Jan 10, 2025 8-K Results of operations (earnings release) Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Shareholder vote results Aug 21, 2024 8-K Results of operations (earnings release) Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Entered a material agreement; Other events Jul 26, 2024 8-K Item 5.08; Other events Jun 5, 2024 8-K Director or officer change May 16, 2024 8-K Results of operations (earnings release) May 15, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Entered a material agreement; Other events May 1, 2024